Docosahexaenoic acid, but not eicosapentaenoic acid, lowers ambulatory blood pressure and shortens interval QT in spontaneously hypertensive rats in vivo

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 80, Issue 5-6, 2009, Pages 269-277

  Rousseau Ralliard, Delphine ^a,b   Moreau, Daniel ^c   Guilland, Jean Claude ^d   Raederstorff, Daniel ^d   Grynberg, Alain ^a,b  

^a University Paris Saclay   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Blood pressure monitoring; Dietary n 3 LCPUFA; ECG; Essential hypertension; Heart; Membrane; Phospholipids; SHR; Telemetry

Indexed keywords

ARACHIDONIC ACID; CATECHOLAMINE; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; NORADRENALIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIET THERAPY; FAT INTAKE; HEART PROTECTION; HEART RATE; HYPERTENSION; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT QT INTERVAL; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-6; HYPERTENSION; MALE; MYOCARDIUM; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

ANIMALIA; RATTUS;

EID: 68649122100     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.03.003     Document Type: Article

References (60)

1. Lloyd-Jones D.M., Evans J.C., Larson M.G., O'Donnell C.J., Wilson P.W., and Levy D. Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study. Arch. Intern. Med. 159 (1999) 2206-2212
2. Safar M.E. Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr. Opin. Nephrol. Hypertens. 10 (2001) 257-261
3. Dang A., Zheng D., Wang B., Zhang Y., Zhang P., Xu M., Liu G., and Liu L. The role of the renin-angiotensin and cardiac sympathetic nervous systems in the development of hypertension and left ventricular hypertrophy in spontaneously hypertensive rats. Hypertens. Res. 22 (1999) 217-221
4. Gerova M., and Kristek F. Integrative pattern of vasomotor efficiency in SHR during ontogenesis. Physiol. Res. 57 (2008) 677-684
5. Khono I., Honma H., Nakamura T., and Tamura K. Comparison of blood pressure, heart rate and activity between normotensive and spontaneously hypertensive rats. Chronobiologia 21 (1994) 45-56
6. Yajima Y., Ito S., Komatsu K., Tsukamoto K., Matsumoto K., and Hirayama A. Enhanced response from the caudal pressor area in spontaneously hypertensive rats. Brain Res. 1227 (2008) 89-95
7. Bobik A., Dilley R., and Kanellakis P. Sympatho-adrenal mechanisms regulating cardiovascular hypertrophy in primary hypertension: a role for rilmenidine?. J. Hypertens. Suppl. 16 (1998) S51-S54
8. Udenfriend S., Ooshima A., Cardinale G., Fuller G.C., and Spector S. Increased formation of collagen in the blood vessels of hypertensive rats. Ann. N. Y. Acad. Sci. 275 (1976) 101-103
9. Adams M.A., Bobik A., and Korner P.I. Differential development of vascular and cardiac hypertrophy in genetic hypertension. Relation to sympathetic function. Hypertension 14 (1989) 191-202
10. Engler M.M., Engler M.B., Kroetz D.L., Boswell K.D., Neeley E., and Krassner S.M. The effects of a diet rich in docosahexaenoic acid on organ and vascular fatty acid composition in spontaneously hypertensive rats. Prostaglandins Leukot. Essent. Fatty Acids 61 (1999) 289-295
11. Marin-Garcia J., and Goldenthal M.J. Fatty acid metabolism in cardiac failure: biochemical, genetic and cellular analysis. Cardiovasc. Res. 54 (2002) 516-527
12. Siddiqui R.A., Harvey K.A., and Zaloga G.P. Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health. J. Nutr. Biochem. 19 (2008) 417-437
13. Kris-Etherton P.M., Harris W.S., and Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
14. Holub D.J., and Holub B.J. Omega-3 fatty acids from fish oils and cardiovascular disease. Mol. Cell. Biochem. 263 (2004) 217-225
15. Wang C., Harris W.S., Chung M., Lichtenstein A.H., Balk E.M., Kupelnick B., Jordan H.S., and Lau J. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am. J. Clin. Nutr. 84 (2006) 5-17
16. Russo G.L. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem. Pharmacol. 77 (2009) 937-946
17. Iacono J.M., and Dougherty R.M. Effects of polyunsaturated fats on blood pressure. Annu. Rev. Nutr. 13 (1993) 243-260
18. Rousseau D., Helies-Toussaint C., Raederstorff D., Moreau D., and Grynberg A. Dietary n-3 polyunsaturated fatty acids affect the development of renovascular hypertension in rats. Mol. Cell. Biochem. 225 (2001) 109-119
19. Rousseau D., Helies-Toussaint C., Moreau D., Raederstorff D., and Grynberg A. Dietary n-3 PUFAs affect the blood pressure rise and cardiac impairments in a hyperinsulinemia rat model in vivo. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H1294-H1302
20. Singer P., Gerhard U., Moritz V., Forster D., Berger I., and Heine H. Different changes of n-6 and n-3 fatty acids in adipose tissue from spontaneously hypertensive (SHR) and normotensive rats after diets supplemented with linolenic or eicosapentaenoic acids. Prostaglandins Leukot. Med. 24 (1986) 163-172
21. Mori T.A., Bao D.Q., Burke V., Puddey I.B., and Beilin L.J. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 34 (1999) 253-260
22. Bonaa K.H., Bjerve K.S., Straume B., Gram I.T., and Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso study. N. Engl. J. Med. 322 (1990) 795-801
23. Miura K., and Nakagawa H. Can dietary changes reduce blood pressure in the long term?. Curr. Opin. Nephrol. Hypertens. 14 (2005) 253-257
24. Schmidt E.B., Arnesen H., Christensen J.H., Rasmussen L.H., Kristensen S.D., and De Caterina R. Marine n-3 polyunsaturated fatty acids and coronary heart disease: part II. Clinical trials and recommendations. Thromb. Res. 115 (2005) 257-262
25. Robbez Masson V., Lucas A., Gueugneau A.M., Macaire J.P., Paul J.L., Grynberg A., and Rousseau D. Long-chain (n-3) polyunsaturated fatty acids prevent metabolic and vascular disorders in fructose-fed rats. J. Nutr. 138 (2008) 1915-1922
26. Pauwels E.K., and Kostkiewicz M. Fatty acid facts, part III: cardiovascular disease, or, a fish diet is not fishy. Drug News Perspect. 21 (2008) 552-561
27. Grynberg A., Fournier A., Sergiel J.P., and Athias P. Effect of docosahexaenoic acid and eicosapentaenoic acid in the phospholipids of rat heart muscle cells on adrenoceptor responsiveness and mechanism. J. Mol. Cell Cardiol. 27 (1995) 2507-2520
28. Ayalew-Pervanchon A., Rousseau D., Moreau D., Assayag P., Weill P., and Grynberg A. Long-term effect of dietary {alpha}-linolenic acid or decosahexaenoic acid on incorporation of decosahexaenoic acid in membranes and its influence on rat heart in vivo. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H2296-H2304
29. Massaro M., Scoditti E., Carluccio M.A., and De Caterina R. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot. Essent. Fatty Acids 79 (2008) 109-115
30. Reeves P.G., Nielsen F.H., and Fahey Jr G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123 (1993) 1939-1951
31. Wojenski C.M., Silver M.J., and Walker J. Eicosapentaenoic acid ethyl ester as an antithrombotic agent: comparison to an extract of fish oil. Biochim. Biophys. Acta 1081 (1991) 33-38
32. Nordoy A., Barstad L., Connor W.E., and Hatcher L. Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans. Am. J. Clin. Nutr. 53 (1991) 1185-1190
33. van den Buuse M. Circadian rhythms of blood pressure, heart rate, and locomotor activity in spontaneously hypertensive rats as measured with radio-telemetry. Physiol. Behav. 55 (1994) 783-787
34. Howe P.R. Can we recommend fish oil for hypertension?. Clin. Exp. Pharmacol. Physiol. 22 (1995) 199-203
35. Bazil M.K., Krulan C., and Webb R.L. Telemetric monitoring of cardiovascular parameters in conscious spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 22 (1993) 897-905
36. Delerive P., Oudot F., Ponsard B., Talpin S., Sergiel J.P., Cordelet C., Athias P., and Grynberg A. Hypoxia-reoxygenation and polyunsaturated fatty acids modulate adrenergic functions in cultured cardiomyocytes. J. Mol. Cell. Cardiol. 31 (1999) 377-386
37. Howe P., Provis J., West M., and Chalmers J. Changes in cardiac norepinephrine in spontaneously hypertensive and stroke-prone rats. J. Cardiovasc. Pharmacol. 1 (1979) 115-122
38. Crabb G., Head R., Hempstead J., and Berkowitz B. Altered disposition of vascular catecholamines in hypertensive (DOCA-salt) rats. Clin. Exp. Hypertens. 2 (1980) 129-138
39. McLennan P., Howe P., Abeywardena M., Muggli R., Raederstorff D., Mano M., Rayner T., and Head R. The cardiovascular protective role of docosahexaenoic acid. Eur. J. Pharmacol. 300 (1996) 83-89
40. Sasaki S., Nakamura K., Uchida A., Fujita H., Itoh H., Nakata T., Takeda K., and Nakagawa M. Effects of gamma-linolenic and eicosapentaenoic acids on blood pressure in SHR. Clin. Exp. Pharmacol. Physiol. Suppl. 1 (1995) S306-S307
41. Nasa Y., Sakamoto Y., Sasaki H., Yamagushi F., and Takeo S. Changes in fatty acid compositions of myocardial lipids in rats with heart failure following myocardial infarction. Mol. Cell. Biochem. 176 (1997) 179-189
42. Smulyan H., and Safar M.E. The diastolic blood pressure in systolic hypertension. Ann. Intern. Med. 132 (2000) 233-237
43. van Gorp A.W., Schenau D.S., Hoeks A.P., Boudier H.A., de Mey J.G., and Reneman R.S. Spontaneously hypertensive rats alterations in aortic wall properties precede development of hypertension. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H1241-H1247
44. Owen A.J., Peter-Przyborowska B.A., Hoy A.J., and McLennan P.L. Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition. Lipids 39 (2004) 955-961
45. Klimas J., Stankovicova T., Kyselovic J., and Bacharova L. Prolonged QT interval is associated with blood pressure rather than left ventricular mass in spontaneously hypertensive rats. Clin. Exp. Hypertens. 30 (2008) 475-485
46. Extramiana F., Tavernier R., Maison-Blanche P., Neyroud N., Jordaens L., Leenhardt A., and oumel P. Ventricular repolarization and Holter monitoring. Effect of sympathetic blockage on the QT/RR ratio. Arch. Mal. Coeur Vaiss. 93 (2000) 1277-1283
47. Durot I., Athias P., Oudot F., and Grynberg A. Influence of phospholipid long chain polyunsaturated fatty acid composition on neonatal rat cardiomyocyte function in physiological conditions and during glucose-free hypoxia-reoxygenation. Mol. Cell. Biochem. 175 (1997) 253-262
48. Hirafuji M., Ebihara T., Kawahara F., and Minami M. Effect of docosahexaenoic acid on smooth muscle cell functions. Life Sci. 62 (1998) 1689-1693
49. GISSI. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico [see comments]. Lancet 354 (1999) 447-455
50. Charnock J.S., McLennan P.L., and Abeywardena M.Y. Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol. Cell. Biochem. 116 (1992) 19-25
51. Ollerenshaw J., Heagerty A., Bing R., and Swales J. Abnormalities of erythrocyte membrane fatty acid. Composition in human essential hypertension. J. Hum. Hypertens. 1 (1987) 9-12
52. Millanvoye-Van Brussel E., Simon J., and Freyss-Beguin M. Altered phospholipid fatty acid content and metabolism in heart cell cultures from newborn spontaneously hypertensive rats. Am. J. Hypertens. 7 (1994) 953-959
53. Emilsson A., and Gudbjarnason S. Reversible alterations of fatty acid profile of glycerophospholipids in rat heart muscle induced by repeated norepinephrine administration. Biochem. Biophys. Acta 750 (1983) 1-6
54. Liautaud S., Grynberg A., Mourot J., and Athias P. Fatty acids of hearts from rats fed linseed or sunflower oil and of cultured cardiomyocytes grown on their sera. Cardioscience 2 (1991) 55-61
55. Battle T., Arnal J.F., and Michel J.B. Hyperproliferation of aortic smooth muscle cells and fibroblasts from young SHR rats is not shared by endothelial cells. Clin. Exp. Pharmacol. Physiol. 21 (1994) 981-989
56. Ratnayake W., Plouffe L., Hollywood R., L'Abbé M., Hidiroglou N., Sarwar G., and Mueller R. Influence of sources of dietary oils on the life span of stroke-prone spontaneously hypertensive rats. Lipids 35 (2000) 409-420
57. Yerram N.R., and Spector A.A. Effects of omega-3 fatty acids on vascular smooth muscle cells: reduction in arachidonic acid incorporation into inositol phospholipids. Lipids 24 (1989) 594-602
58. Chen H.W., Lii C.K., Chen W.T., Wang M.L., and Ou C.C. Blood pressure-lowering effect of fish oil is independent of thromboxane A2 level in spontaneously hypertensive rats. Prostaglandins Leukot. Essent. Fatty Acids 54 (1996) 147-154
59. Brandle M., and Jacob R. Effects of a diet rich in Q-3 fatty acids on left ventricular geometry and dynamics in spontaneously hypertensive rats. Eur. J. Appl. Physiol. 61 (1990) 177-181
60. Mitasikova M., Smidova S., Macsaliova A., Knezl V., Dlugosova K., Okruhlicova L., Weismann P., and Tribulova N. Aged male and female spontaneously hypertensive rats benefit from n-3 polyunsaturated fatty acids supplementation. Physiol. Res. 57 Suppl. 2 (2008) S39-S48